PC(18:3(9Z,12Z,15Z)/20:1(11Z))
|
Basic information |
| Metabolite name | PC(18:3(9Z,12Z,15Z)/20:1(11Z)) |
 | HMDB0008209 |
 |
C00157 |
 |
52922857 |
| Synonyms | NA |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | PC(18:3(9Z,12Z,15Z)/20:1(11Z)) |
| HMDB0008209 |
|
C00157 |
|
52922857 |
| Synonyms | NA |
| No. of studies | 1 |
|
Relationship between PC(18:3(9Z,12Z,15Z)/20:1(11Z)) and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M210 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M210 | Type2 | CUMS + venlafaxine group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M210 | Type2 | CUMS + curcumin group vs. CUMS group | Serum | Sprague-Dawley rat | Up |